David Stanton
Stock Analyst at Jefferies
(4.10)
# 1,574
Out of 4,455 analysts
209
Total ratings
44.3%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by David Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $22.55 → $22.60 | $20.42 | +10.68% | 20 | Jun 21, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Buy | $0.90 → $0.80 | $0.71 | +12.68% | 10 | Jun 12, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $195.00 → $108.00 | $114.87 | -5.98% | 23 | May 29, 2026 | |
| ASX: HLS Healius Limited | Maintained: Hold | $0.81 → $0.45 | $0.365 | +23.29% | 16 | May 13, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Maintained: Buy | $3.05 → $3.30 | $2.77 | +19.13% | 17 | May 5, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $40.00 → $39.20 | $9.99 | +292.39% | 10 | Apr 24, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $285.00 → $137.00 | $118.03 | +16.07% | 18 | Apr 23, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $24.30 → $27.40 | $15.33 | +78.73% | 22 | Apr 15, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $3.30 → $2.80 | $1.89 | +48.54% | 15 | Apr 9, 2026 | |
| ASX: IMM Immutep Limited | Downgraded: Hold | $2.10 → $0.04 | $0.048 | -16.67% | 8 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.60 → $27.00 | $12.20 | +121.31% | 16 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5.00 | $1.82 | +175.48% | 11 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38.65 → $34.50 | $43.10 | -19.95% | 11 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 → $3.50 | $2.00 | +75.00% | 8 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.19 | n/a | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.00 | n/a | 3 | Apr 8, 2021 |
Sonic Healthcare Limited
Jun 21, 2026
Maintained: Hold
Price Target: $22.55 → $22.60
Current: $20.42
Upside: +10.68%
Monash IVF Group Limited
Jun 12, 2026
Maintained: Buy
Price Target: $0.90 → $0.80
Current: $0.71
Upside: +12.68%
CSL Limited
May 29, 2026
Downgraded: Hold
Price Target: $195.00 → $108.00
Current: $114.87
Upside: -5.98%
Healius Limited
May 13, 2026
Maintained: Hold
Price Target: $0.81 → $0.45
Current: $0.365
Upside: +23.29%
Sigma Healthcare Limited
May 5, 2026
Maintained: Buy
Price Target: $3.05 → $3.30
Current: $2.77
Upside: +19.13%
Clinuvel Pharmaceuticals Limited
Apr 24, 2026
Maintained: Buy
Price Target: $40.00 → $39.20
Current: $9.99
Upside: +292.39%
Cochlear Limited
Apr 23, 2026
Maintained: Buy
Price Target: $285.00 → $137.00
Current: $118.03
Upside: +16.07%
Telix Pharmaceuticals Limited
Apr 15, 2026
Maintained: Buy
Price Target: $24.30 → $27.40
Current: $15.33
Upside: +78.73%
Mesoblast Limited
Apr 9, 2026
Maintained: Buy
Price Target: $3.30 → $2.80
Current: $1.89
Upside: +48.54%
Immutep Limited
Mar 13, 2026
Downgraded: Hold
Price Target: $2.10 → $0.04
Current: $0.048
Upside: -16.67%
Feb 5, 2026
Maintained: Buy
Price Target: $28.60 → $27.00
Current: $12.20
Upside: +121.31%
Dec 16, 2025
Upgraded: Buy
Price Target: $5.00
Current: $1.82
Upside: +175.48%
Aug 28, 2025
Maintained: Hold
Price Target: $38.65 → $34.50
Current: $43.10
Upside: -19.95%
Aug 26, 2025
Maintained: Buy
Price Target: $3.30 → $3.50
Current: $2.00
Upside: +75.00%
Dec 6, 2022
Downgraded: Hold
Price Target: n/a
Current: $13.19
Upside: n/a
Apr 8, 2021
Downgraded: Hold
Price Target: n/a
Current: $14.00
Upside: n/a